Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alexandre V. Hirayama

Toxicities of CD19 CAR-T Cell Immunotherapy

American Journal of Hematology

English

Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T Cells Alone or in Combination With Ibrutinib for Relapsed and/or Refractory CLL

Biology of Blood and Marrow Transplantation

Transplantation

English

Related publications

High Rate of Durable Complete Remission in Follicular Lymphoma After Cd19 Car-T Cell Immunotherapy

Hematological Oncology

Cancer Research

English

Durable Responses After CD19-targeted CAR-T Cell Immunotherapy With Concurrent Ibrutinib for CLL After Prior Ibrutinib Failure

Hematological Oncology

Cancer Research

English

CAR-T Cells Beyond CD19, UnCAR-Ted Territory

American Journal of Hematology

English

Improving CAR T Cell Immunotherapy–mediated Remissions for Pediatric Leukemia

Journal of Clinical Investigation

English

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Hematological Oncology

Cancer Research

English

Hurdles of CAR-T Cell-Based Cancer Immunotherapy Directed Against Solid Tumors

Science China Life Sciences

Molecular Biology

Environmental Science

Biological Sciences

English

Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy

Hematological Oncology

Cancer Research

English

Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy

American Journal of Hematology

English

Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy

British Journal of Haematology

English